CAS: 2271036-44-1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Pomalidomide-PEG1-C2-N3 REF: AN-AG01MVLPCAS: 2271036-44-1 | 98% | 481,00 € | Jue 11 Jul 24 |
 | Pomalidomide-PEG1-C2-N3 REF: TM-T17904CAS: 2271036-44-1 | 98% | A consultar | Vie 12 Jul 24 |
 | Pomalidomide-PEG1-C2-N3 REF: 10-F986941CAS: 2271036-44-1 | - - - | 234,00 € | Mar 16 Jul 24 |
 | Pomalidomide-PEG1-C2-N3 REF: 3D-WQD03644CAS: 2271036-44-1 | Min. 95% | A consultar | Jue 22 Ago 24 |
Pomalidomide-PEG1-C2-N3
CAS:2271036-44-1
Pomalidomide-PEG1-C2-N3 is a compound that has been synthesized as a conjugate of an E3 ligase …
Fórmula:
C17H18N6O5
Pureza:
98%
Peso molecular:
386.36
Ref: TM-T17904
| 2mg | 49,00 € |
Entrega estimada en Estados Unidos, el Viernes 12 de Julio de 2024
Ref: 10-F986941
| 25mg | 234,00 € |
Entrega estimada en Estados Unidos, el Martes 16 de Julio de 2024
Pomalidomide-PEG1-C2-N3
CAS:2271036-44-1
Pomalidomide-PEG1-C2-N3 is a small molecule that activates the S1P receptor. The molecular weight of this …
Fórmula:
C17H18N6O5
Pureza:
Min. 95%
Peso molecular:
386.4 g/mol
Ref: 3D-WQD03644
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 22 de Agosto de 2024
